The effects of variable doses of STW 5 and STW 5-II on bacterial isolates from the duodenum and the duodenal mucosa-associated microbiomes from subjects with and without functional GI symptoms (2022–2023)
- Grant type:
- Bayer - Steigerwald Arzneimittelwerk GmbH
- Researchers:
-
-
- Funded by:
- Bayer - Steigerwald Arzneimittelwerk GmbH
